Welcome to Dynamic Entropy Technology LLC
Our Business & Products
-
Contract Research & Development Services
-
Biomineralization process development
-
Wound-healing Collagen Dressings (Trademark Collagenized Dressings™)
-
Vaccine formulation
-
Drug delivery
-
Biomass and biochemicals (including biofuels)
CEO
Dr. Mark Feng
OUR MISSIONS
-
To develop new technologies in health sciences for better life of human beings through innovations and technology transfer
-
To provide R&D services for government, universities, and industries.
Our Key Advantages
-
Over 20 Years of Experiences
-
Inventor of multiple U.S. Patents
-
Short turnaround time
-
Low indirect cost (<40%)
Our Technologies
Drug, gene and vaccine delivery (Formulation)
Wound-healing dressings development and fabrication
Biomaterials (polymers, ceramics, proteins, hybrids)
Nanoparticles (Au, magnetic, CaP, Polymer, Lipid, etc.)
Delivery substrates from aligned polymer biomaterials for tissue repair
Bioencapsulation and Nanomedicine
Oral, intranasal, transdermal, intravenous, intramuscular, intracranial, intraosseous delivery
Antimicrobial product development
Tissue engineering and regeneration
Our Facilities
Chemical Reactors (Batch & Continuous), Furnace, Catalyst Manufacturing, Chromatography, Electrophoresis, Biomaterial /nanoparticle characterization, Microscopies, Emulsions, Lipid Extrusion and sonication, ISO9001:2015, GLP, cGMP, ISO1485 to be certified.
Pilot plant scale biomass utilization and biofuel production
Funding News
-
On October 2020, DET is awarded a Phase I small business technology transfer (STTR) grant from NSF ($256,000). The work is to develop an intranasal nano vaccine for COVID-19.
-
On September 2019, we received a Phase I small business technology transfer (STTR) award ($225,000) from NIH. The project is antibacterial/antifungal polymer technology as medical devices for diabetic skin infections.